Postoperative pain control for outpatient oral surgery

Area of Science:

• Oral Surgery
• Pharmacology
• Pain Management

Background:

• Impacted mandibular third molars are a common surgical challenge.
• Effective postoperative pain control is crucial for patient recovery and satisfaction.
• Traditional pain management often involves short-acting analgesics and local anesthetics.

Purpose of the Study:

• To evaluate the efficacy of a long-acting anti-inflammatory (diflunisal) combined with a long-acting local anesthetic (bupivacaine) for postoperative pain control.
• To compare this novel treatment regimen against a traditional approach using paracetamol with codeine and lignocaine.
• To assess patient preference and pain levels over the initial postoperative period.

Main Methods:

• A double-blind, randomized crossover trial involving 16 healthy patients undergoing bilateral impacted mandibular third molar extraction.
• Utilized a visual analogue pain scale for quantitative pain assessment.
• Compared diflunisal/bupivacaine treatment with paracetamol/codeine/lignocaine treatment.

Main Results:

• Patients reported significantly reduced postoperative pain during the first 4 days with the diflunisal/bupivacaine regimen.
• Patient preference for the diflunisal/bupivacaine treatment was highly significant.
• No significant side-effects or adverse reactions were observed with either treatment.

Conclusions:

• The combination of diflunisal and bupivacaine offers superior and prolonged postoperative pain relief for impacted mandibular third molar surgery.
• This regimen represents a significant advancement in oral surgery pain management.
• Further research into long-term use of diflunisal in oral surgery is warranted.